-
Boost for VRX-GSK Epilepsy Drug - Analyst Blog
Tuesday, January 25, 2011 - 10:01am | 579Valeant Pharmaceuticals International (VRX) and GlaxoSmithKline plc (GSK) recently said that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended the approval of epilepsy drug, retigabine. The companies had submitted the Marketing Authorization...
-
Boost for VRX-GSK Epilepsy Drug - Analyst Blog
Tuesday, January 25, 2011 - 9:45am | 579Valeant Pharmaceuticals International (VRX) and GlaxoSmithKline plc (GSK) recently said that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended the approval of epilepsy drug, retigabine. The companies had submitted the Marketing Authorization...
-
Biogen-Acorda MS Drug Faces Setback - Analyst Blog
Monday, January 24, 2011 - 12:31pm | 642Biogen Idec (BIIB) recently faced a pipeline setback with the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) recommending against the approval of oral drug Fampyra (US trade name: Ampyra), aimed at improving walking speed in patients suffering from...
-
Biogen-Acorda MS Drug Faces Setback - Analyst Blog
Monday, January 24, 2011 - 11:45am | 642Biogen Idec (BIIB) recently faced a pipeline setback with the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) recommending against the approval of oral drug Fampyra (US trade name: Ampyra), aimed at improving walking speed in patients suffering from...
-
Courier Signs Multiyear Book Manufacturing Agreement with Pearson Education
Friday, January 21, 2011 - 8:34am | 91Courier Corporation (Nasdaq: CRRC) today announced that it has signed a multiyear book manufacturing agreement with Pearson Education, the world's largest educational publisher. For Courier, the third-largest book manufacturer in North America, the agreement follows a year of above-market growth...
-
Top 4 Stocks In The Publishing-Books Industry With The Highest EPS Estimates (MHP, SCHL, CRRC, PSO)
Thursday, January 20, 2011 - 3:47am | 146Below are the top publishing-book stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next year. The earnings estimate for McGraw-Hill Companies Inc (The) (NYSE: MHP) for the next year ending December, 2011 is $2.89 per share. MHP's PEG ratio is 1.20. Scholastic Corporation (...
-
Courier Corporation Declares Dividend of $.21
Tuesday, January 18, 2011 - 8:38am | 48The Board of Directors of Courier Corporation (Nasdaq: CRRC), has declared a dividend of 21.0 cents per common share, payable February 25, 2011 to stockholders of record on February 11, 2011. The amount of the dividend is the same as declared in the previous quarter.
-
Courier Reports Q1 EPS of $.14
Tuesday, January 18, 2011 - 8:33am | 122Courier Corporation (Nasdaq: CRRC) today announced results for the quarter ended December 25, 2010, the first quarter of its 2011 fiscal year. Revenues for the quarter were $61.2 million, down 3% from last year's first-quarter sales of $63.1 million. Net income for the quarter was $1.7 million or...
-
Earnings Scheduled For January 18 (IBM, AAPL, DAL, FAST, AMTD, C, LLTC, CRRC, FRX, WDC, CREE)
Tuesday, January 18, 2011 - 3:27am | 291International Business Machines Corp (NYSE: IBM) is expected to report its Q4 earnings at $4.08 per share on revenue of $28.26 billion. Apple Inc (NASDAQ: AAPL) is likely to report its FQ4 EPS at $5.38 on revenue of $24.38 billion. Delta Air Lines Inc (NYSE: DAL) is forecast to post its earnings at...
-
Lucentis Gains EU Approval for DME - Analyst Blog
Thursday, January 13, 2011 - 8:46am | 554Novartis AG (NVS) recently received European approval for Lucentis to treat patients with certain forms of diabetic macular edema (DME). It is an eye condition related to long-standing diabetes that may lead to blindness, particularly in working-age population in most developed countries....
-
Lucentis Gains EU Approval for DME - Analyst Blog
Thursday, January 13, 2011 - 8:00am | 554Novartis AG (NVS) recently received European approval for Lucentis to treat patients with certain forms of diabetic macular edema (DME). It is an eye condition related to long-standing diabetes that may lead to blindness, particularly in working-age population in most developed countries....
-
Wednesday's Put/Call Ratio Leaders (RRD, AMAG, WMB, AGO, AIXG)
Wednesday, January 12, 2011 - 12:55pm | 94Here is a quick peek at stocks that have abnormally high daily put/call ratios today relative to their average…. 1. R.R. Donnelley & Sons (NYSE: RRD) 3,109 puts, 82 calls 2. AMAG Pharmaceuticals (NASDAQ: AMAG) 4,657 puts, 175 calls 3. Williams Companies (NYSE: WMB) 26,357 puts, 2,107 calls 4....
-
Options Brief: R.R. Donnelley & Sons (RRD)
Wednesday, January 12, 2011 - 12:42pm | 78Shares of R.R. Donnelley & Sons (NYSE: RRD) are higher on the session by 1.80%, trading at $18.08. Overall put volume is now running at 8.94x the daily average, with 4% of all puts traded being purchases on the offer. 1,753 contracts have traded on the session so far. R.R. Donnelley & Sons...
-
Options Brief: R.R. Donnelley & Sons (RRD)
Monday, January 10, 2011 - 11:42am | 78Shares of R.R. Donnelley & Sons (NYSE: RRD) are lower on the session by 0.18%, trading at $17.59. Overall put volume is now running at 31.91x the daily average, with 0% of all puts traded being purchases on the offer. 1,500 contracts have traded on the session so far. R.R. Donnelley & Sons...
-
Top 4 Mid-Cap Stocks In The Business Services Industry With The Highest Dividend Yield (RRD, RBA, CTAS, TSS)
Thursday, January 6, 2011 - 3:57am | 124Below are the top mid-cap business service stocks on the NYSE and the NASDAQ in terms of dividend yield. R.R. Donnelley & Sons Company (NASDAQ: RRD) has a dividend yield of 5.90%. RRD's shares closed at $17.54 yesterday. Ritchie Bros. Auctioneers Inc (NYSE: RBA) has a dividend yield of 1.80%....